R12 Kapital AB increases its shareholding in Capio AB (publ)
R12 Kapital, which is one of the cornerstone investors in Capio, has decided to exercise its right to acquire an additional 1 percent of the shares in Capio from the selling shareholder Ygeia Equity AB. After the transaction, which was completed on September 30, 2015, R12 Kapital controls 7.2 percent of the capital and votes in Capio.
Information about R12 Kapital’s right to acquire additional shares in Capio is available in the Prospectus issued in connection with the listing of Capio and is found at http://capio.com/en/investors/initial-public-offering/.
For information, please contact:
Olof Bengtsson, CFO
Telephone: +46 761 18 74 69
Henrik Brehmer, SVP Corporate Communications and Public Affairs
Telephone: +46 761 11 34 14
Capio AB (publ) is required to publish the above information under the Swedish Financial Instruments Trading Act. The information was submitted for publication on September 30, 2015 at 15.00 CET.
Capio AB (publ) is a leading, pan-European healthcare provider offering a broad range of high quality medical, surgical and psychiatric healthcare services in four countries through its hospitals, specialist clinics and primary care units. In 2014, Capio’s 12,357 employees provided healthcare services during 4.6 million patient visits across the Group’s facilities in Sweden, Norway, France and Germany, generating net sales of MSEK 13,200. Capio operates across three geographic segments: Nordic (54 percent of Group net sales 2014), France (37 percent of Group net sales 2014) and Germany (9 percent of Group net sales 2014). For more information about Capio, please see www.capio.com.